Alzheimer's Disease News and Research

RSS

Alzheimer's disease (AD) is an irreversible, progressive brain disease that slowly destroys memory and thinking skills and, eventually, the ability to carry out the simplest tasks of daily living. In most people with AD, symptoms first appear after age 60. AD is the most common cause of dementia among older people, but it is not a normal part of aging. Dementia refers to a decline in cognitive function that interferes with daily life and activities. AD starts in a region of the brain that affects recent memory, then gradually spreads to other parts of the brain. Although treatment can slow the progression of AD and help manage its symptoms in some people, currently there is no cure for this devastating disease.

Research presents new approach to identify therapeutic targets for human diseases associated with protein phase separation

Recent research demonstrates that protein phase separation (PPS) is widely present in cells and drives a variety of important biological functions.

25 Sep 2023

Scientists decode the marker protein that can be used to ‘‘see’’ neuroinflammation

Inflammation is the sign that our body is defending itself against an aggression. But when this response escalates, for example in the brain, it can lead to serious neurological or psychiatric diseases.

25 Sep 2023

Study reveals non-coding genetic variants associated with Alzheimer’s disease functioning in microglia

Scientists studying Alzheimer's disease (AD) have identified thousands of genetic variants in the genome in the development of this progressive neurodegenerative disease.

23 Sep 2023

Photobiomodulation in sleep has more therapeutic effects for Alzheimer's disease than in wakefulness

It is well known that sleep is the best medication. However, it is still unknown why the brain recovers better in sleep and whether these processes can be controlled.

22 Sep 2023

Scientists discover novel microglia-associated risk factors for Alzheimer's disease

Scientists studying Alzheimer's disease (AD) have identified thousands of genetic variants in the genome in the development of this progressive neurodegenerative disease.

22 Sep 2023

Decoding tauopathies: New study identifies non-coding RNA as a key player in Alzheimer's

Researchers at Washington University School of Medicine identify a key step in the development of harmful tau tangles, offering a potential target for preventing brain damage in diseases like Alzheimer's. The study highlights the role of long noncoding RNAs, particularly SNHG8, in stress granule formation and tau aggregation, opening new avenues for treatment.

22 Sep 2023

Is hemp the superfood vegetarians have been waiting for?

This recent study in the journal Nutrients delves into the nutritional power of hemp seeds, highlighting their potential as a rich source of proteins, essential fatty acids, and dietary fiber—particularly valuable for vegetarians. The paper also suggests that hemp could offer numerous health benefits, from antioxidant activity to potentially aiding in metabolic and cardiovascular diseases, paving the way for more focused research.

22 Sep 2023

Does arsenic exposure cause mortality due to cancer, diabetes, Alzheimer's and congenital anomalies?

The association between arsenic exposure due to groundwater contamination and mortality rates.

21 Sep 2023

FAU awarded $1.3 million grant to improve quality of life for individuals with dementia and their families

Florida Atlantic University's María de los Ángeles Ortega, DNP, APRN, in the Christine E. Lynn College of Nursing, has been awarded a three-year, $1.3 million grant from the Administration for Community Living's (ACL) Alzheimer's Disease Program Initiative for a groundbreaking project designed to advance health equity and improve quality of life for individuals living with or at high risk for Alzheimer's disease and related dementias (ADRD) and their family caregivers.

20 Sep 2023

Telecare improves outcomes for patients with dementia and lightens the load for unpaid caregivers

A UCSF telecare program that improves outcomes for patients with dementia and lightens the load for unpaid caregivers also has the surprising bonus of cutting Medicare costs, according to UC San Francisco research.

19 Sep 2023

Gaining new insights into neurological diseases by studying circular RNAs in brain cells

Researchers are gaining new insights into neurological diseases by studying circular RNAs (circRNAs) in brain cells.

19 Sep 2023

New immunoregulatory protein linked to autoimmune disease

Autoimmune diseases are complex illnesses, the causes of which are diverse and have not yet been fully explained.

18 Sep 2023

BU researchers receive NIH grant to identify genetic factors for Alzheimer's disease

The National Institutes of Health/National Institute on Aging recently awarded a $13.7 million grant to a project led by Boston University Chobanian & Avedisian School of Medicine principal investigators Lindsay Farrer, PhD, chief of biomedical genetics and distinguished professor of genetics, and Richard Sherva, PhD, assistant professor of medicine in biomedical genetics, for research using whole genome sequencing and other approaches to identify genetic factors for Alzheimer disease (AD) in Jews currently living in Israel who trace their ancestors to southern Spain and locations in the Middle East and North Africa (MENA) and Arab citizens of Israel.

15 Sep 2023

Rural nursing home supporters fear proposed staffing standards will trigger more closures

Many rural communities like this one face a health care dilemma: Is it better to have a nursing home that struggles to hire workers or no nursing home at all?

15 Sep 2023

Is maple syrup the ultimate natural sweetener? Researchers say it's more than just tasty!

Scientists explore the myriad benefits of maple syrup, revealing its nutritional, pharmacological, and sensory advantages over traditional sweeteners. From antioxidant and anti-inflammatory properties to controlling blood sugar and even potential anticancer effects, maple syrup is more than just a tasty topping.

14 Sep 2023

Researchers discover backup protein quality control mechanism

Researchers from the Babraham Institute, UK, and the German Center for Neurodegenerative Diseases (DZNE) have identified a backup mechanism of protein quality control which prevents the toxic effects of protein aggregation in specific tissues when normal methods of molecular monitoring fail.

14 Sep 2023

Research opens up new directions to develop drugs for stopping cytokine storms

Constant exposure of cells to stressing agents, such as pathogens, may disturb an organism's normal functioning. To fight stress, cells have developed several coping mechanisms, including the inflammatory response.

14 Sep 2023

People who require specialized neurologic care most often travel long distances, study finds

Nearly one in five people on Medicare travel 50 or more miles one way to see a neurologist, a doctor who diagnoses and treats diseases of the brain and nervous system, according to research published in the September 13, 2023, online issue of Neurology®, the medical journal of the American Academy of Neurology.

13 Sep 2023

Unhealthy pathobiome in the brain could cause some forms of Alzheimer's and related dementias

The human microbiome includes the genetic material of more than 100 trillion tiny microorganisms – fungi, yeast, bacteria, and even viruses, most of which hang out in our gastrointestinal tract to serve as guardians of our health.

13 Sep 2023

Researchers develop new protocol to study white matter injury in Alzheimer's disease

A new editorial paper was published in Aging (listed by MEDLINE/PubMed as "Aging (Albany NY)" and "Aging-US" by Web of Science) Volume 15, Issue 16, entitled, "Microvascular contributions to white matter injury in Alzheimer's disease."

13 Sep 2023

Alzheimer's Disease News and Research

Further Reading

Research presents new approach to identify therapeutic targets for human diseases associated with protein phase separation

Scientists decode the marker protein that can be used to ‘‘see’’ neuroinflammation

Study reveals non-coding genetic variants associated with Alzheimer’s disease functioning in microglia

Photobiomodulation in sleep has more therapeutic effects for Alzheimer's disease than in wakefulness

Scientists discover novel microglia-associated risk factors for Alzheimer's disease

Decoding tauopathies: New study identifies non-coding RNA as a key player in Alzheimer's

Is hemp the superfood vegetarians have been waiting for?

Does arsenic exposure cause mortality due to cancer, diabetes, Alzheimer's and congenital anomalies?

FAU awarded $1.3 million grant to improve quality of life for individuals with dementia and their families

Telecare improves outcomes for patients with dementia and lightens the load for unpaid caregivers

Gaining new insights into neurological diseases by studying circular RNAs in brain cells

New immunoregulatory protein linked to autoimmune disease

BU researchers receive NIH grant to identify genetic factors for Alzheimer's disease

Rural nursing home supporters fear proposed staffing standards will trigger more closures

Is maple syrup the ultimate natural sweetener? Researchers say it's more than just tasty!

Researchers discover backup protein quality control mechanism

Research opens up new directions to develop drugs for stopping cytokine storms

People who require specialized neurologic care most often travel long distances, study finds

Unhealthy pathobiome in the brain could cause some forms of Alzheimer's and related dementias

Researchers develop new protocol to study white matter injury in Alzheimer's disease

Human iPSCs: A Full Guide to Advanced in Vitro Models and Applications eBook

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer

Latest News